Skip to content
Application 103000
- Type
- BLA
- Sponsor
- ALLERGAN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | BOTOX | OnabotulinumtoxinA | VIAL; SINGLE-USE | 50 UNITS/VIAL | No | No |
| 002 | BOTOX | OnabotulinumtoxinA | VIAL; SINGLE-USE | 100 UNITS/VIAL | No | No |
| 003 | BOTOX | OnabotulinumtoxinA | VIAL; SINGLE-USE | 200 UNITS/VIAL | No | No |
| 004 | BOTOX COSMETIC | OnabotulinumtoxinA | VIAL; SINGLE-USE | 50 UNITS/VIAL | No | No |
| 005 | BOTOX COSMETIC | OnabotulinumtoxinA | VIAL; SINGLE-USE | 100 UNITS/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-1145 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3919 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-3921 | BOTOX | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |
| 0023-9232 | BOTOX Cosmetic | onabotulinumtoxinA | Allergan, Inc. | BLA | Current |